NEW YORK (GenomeWeb) – DxTerity said today that it is collaborating with City of Hope Medical Center to develop a blood test to predict whether cancer patients are likely to benefit from radiation therapy or are at risk for radiation toxicity.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.